Overview
Ryunosuke Yoshino practices practicing medicine in Tsukuba, Japan.
His clinical expertise encompasses Chagas Disease, Multiple Endocrine Neoplasia Type 2, and Multiple Endocrine Neoplasia.
He is actively involved in clinical research, co-authoring 30 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryunosuke Yoshino
Is Ryunosuke Yoshino a top-rated expert for Chagas Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Ryunosuke Yoshino is classified as an Experienced expert for Chagas Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryunosuke Yoshino participate in research or clinical trials?
Yes. Ryunosuke Yoshino has published 30 articles and abstracts on conditions like Chagas Disease. You can view a list of Ryunosuke Yoshino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chagas DiseaseMr. Yoshino isExperienced. Learn about Chagas Disease.
- Multiple Endocrine NeoplasiaMr. Yoshino isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 2Mr. Yoshino isExperienced. Learn about Multiple Endocrine Neoplasia Type 2.